Atlas Genetics
Molecular diagnostics at Point-of-Care
Atlas Genetics has raised €32M across 1 funding round from 7 investors, most recently a Series D+ round in Jan 2017. Based in Bristol, UK; founded 2005; active in Healthtech. Data as of 4 Nov 2026.
Total raised
€32M
€31,900,000
Funding rounds
1
Investors
7
distinct backers
Active since
2017-01
latest 2017-01
Funding by year
EUR raised per yearAtlas Genetics — funding by year — interactive chart.
Data table
| Atlas Genetics — funding by year | |
|---|---|
| 2016 | €32M |
Signals
High confidenceRaise-next likelihood10
base rate 53% for Series D+
- ▼ Dormant (no round in 3+ cohort gaps)
- ▼ Low backer re-investment
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2017-01-01 | Series D+ | €32M | BB Biotech Ventures,Global Life Science Ventures,Johnson & Johnson Innovation,Novartis Venture Fund,RMI Partners,Technology Venture Partners+1 more | View deal → |
Investors
7Related news
Similar companies
same sector, similar size- NightstaRx€32MUK · Healthtech
- ALung Technologies€34MUK · Healthtech
- PREP Biopharm€29MUK · Healthtech
- DNAe LTD€35MUK · Healthtech
- StarLeaf€37MUK · Healthtech
- Pulmocide€28MUK · Healthtech
Global coverage: FundingData